Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > PLI was/is very profitable for me
View:
Post by DryBones on Aug 24, 2016 12:16pm

PLI was/is very profitable for me

And will continue to be.

But does this deal men that PLI gets the vaccine plant for free?.  I thought we had around .15 cash?
Comment by TigerDawn on Aug 24, 2016 12:21pm
Cash burn might also be higher than we realize.
Comment by DryBones on Aug 24, 2016 4:46pm
arbitrage.  50 million shares at .005 is $250,000.  This is how you change chickenshit to chickensalad boys.
Comment by PROtrading on Aug 24, 2016 6:12pm
And you want people to eat the salad???
Comment by DryBones on Aug 24, 2016 10:15pm
it tastes better than what we have been fed before.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities